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Abstract
Background: Electronic clinical decision support (CDS) is increasingly establishing its role in evidence-based clinical
practice. Considerable evidence supports its enhancement of efficiency in e-Prescribing, but some controversy
remains. This study evaluated the practicality and identified the perceived benefits of, and barriers to, its future
adoption in the West of Ireland.
Methods: This cross sectional study was carried out by means of a 27-part questionnaire sent to 262 registered
general practitioners in Counties Galway, Mayo and Roscommon. The survey domains encompassed general
information of individual’s practice, current use of CDS and the practitioner’s attitudes towards adoption of CDS-eP.
Descriptive and inferential analyses were performed to analyse the data collected.
Results: The overall response rate was 37%. Nearly 92% of respondents employed electronic medical records in
their practice. The majority acknowledged the value of electronic CDS in improving prescribing quality (71%) and
reducing prescribing errors (84%). Despite a high degree of unfamiliarity (73%), the practitioners were open to the
use of CDS-eP (94%) and willing to invest greater resources for its implementation (62%). Lack of a strategic
implementation plan (78%) is the main perceived barrier to the incorporation of CDS-eP into clinical practice,
followed by i) lack of financial incentives (70%), ii) lack of standardized product software (61%), iii) high sensitivity
of drug-drug interaction or medication allergy markers (46%), iv) concern about overriding physicians’ prescribing
decisions(44%) and v) lack of convincing evidence on the systems’ effectiveness (22%).
Conclusions: Despite favourable attitudes towards the adoption of CDS-eP, multiple perceived barriers impede its
incorporation into clinical practice. These merit further exploration, taking into consideration the structure of the
Irish primary health care system, before CDS-eP can be recommended for routine clinical use in the West of
Ireland.
Background
The introduction of electronic prescribing (e-Prescrib-
ing) a decade ago, whether adopted alone or functionally
incorporated into electronic medical record (EMR) regi-
mens, has transformed prescribing practice. The pro-
posed incorporation of clinical decision support (CDS)
mechanisms such as formulary prescription, drug-drug
interaction checking and drug allergy checking, into e-
Prescribing provides a means of optimizing the prescrib-
ing process, including stewardship for prescribing deci-
sions and enhancement of the safety and
appropriateness of a prescription [1]. It potentially
improves the communication pathway between prescri-
bers and dispensers, as well as augmenting the cost-
effectiveness of national healthcare planning [1,2].
There is considerable evidence supporting the role of
CDS within e-Prescribing (CDS-eP) in enhancing pre-
scribing efficiency [1,3-6], however some controversy
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implementation remain [1,7-9].
In the Irish primary care setting, despite increasing
application of electronic medical records (EMR), the
functions of e-Prescribing have only been partially
adopted and utilized. Currently, the majority of general
practitioners (GPs) utilize the paper mechanisms such
as the British National Formulary (BNF), Monthly Index
of Medical Specialties Ireland (MIMS) and international
or local guidelines, as a reference to support their pre-
scribing decision. Meanwhile, some practitioners employ
electronic mechanisms such as prescribing websites and
software products as an additional reference. To date,
an acceptable and user-friendly CDS-eP has yet to be
developed for the Irish primary care system. However,
recent announcements from the Irish Health Service
Executive (HSE) indicated an extension in its Informa-
tion Technology (IT) strategy to include IT-related pro-
jects, a national electronic prescription system and EMR
implementation [10,11]; this reflects a continued pro-
gress in the Irish e-Health initiative and may provide
opportunity for further research in developing an opti-
mal CDS-eP for primary care.
Prior to implementing a new initiative such as CDS-
eP, thorough assessment of the involved parties is essen-
tial. As prescribers are key players, their understanding,
attitudes and acceptance of this initiative play a decisive
role in determining the success of its implementation.
The current developing trend has therefore led us to
initiate this study with specific aims:
1. to assess, among GPs in the West of Ireland,
a. the prevalence of EMR adoption
b. the current use of CDS mechanism(s) in their
prescribing practice
2. to identify,
a. their perceived benefits of CDS-eP adoption in
future
b. the potential barriers impeding its
implementation
c. their presumptive responses towards potential
alerts flagged by CDS-eP
Methods
Survey instrument
This study was carried out using a cross sectional survey
among GPs in the West of Ireland. A 27-question sur-
vey was developed and evaluated through a pilot study
with five GPs to assess its comprehension and appropri-
ateness. These questions were formulated with reference
to the selected publications [8,9,12,13], reviewed for
their relevance and subsequently categorized into two
sections in the survey.
A short explanatory note was incorporated into the
survey to provide a standardized reference for the
respondents in understanding the two main concepts
central to this study. They were(1) “e-Prescribing (eP)
allows prescribers to utilize electronic systems to facili-
tate and enhance the communication of a prescription,
aiding the choice, administration or supply of a medicine
through decision support and providing a robust audit
trail for the entire medicine use process,” and (2) “Clini-
cal Decision Support within the e-Prescribing context
(CDS-eP) is an algorithm that establishes the safety and
appropriateness of a prescription, with links to a third
party information system employed to enhance the safety
of the prescription. Such systems may include clinical
checks which allow alerts to be flagged up to the prescri-
bers on drug-drug interactions or formulary status” [7].
Section I evaluated the individual GP’sp r a c t i c e ,
including their practice duration in general practice,
practice type and practice premise, prevalence of EMR
adoption and current use of CDS mechanism(s) in their
prescribing practice.
Section II comprised threec o m p o n e n t st oa s s e s st h e
GPs for (i) the benefits they perceived towards CDS-eP
adoption in their clinical practice, (ii) the potential bar-
riers they perceived impeding its implementation in the
primary care setting and (iii) their presumptive
responses to potential alerts flagged by CDS-eP. The
respondents were asked to rate their responses for each
statement using ordinal five-level Likert items [14]. This
survey did not specifically refer to any software currently
in use for e-Prescribing or CDS-eP.
T h es u r v e yw a se n d e dw i t ha no p e nq u e s t i o nf o ra n y
free comments on CDs-eP from the respondents.
Study participants
The questionnaire together with a one-page of persona-
lized introductory cover letter was sent to 262 registered
public and private GPs in Counties Galway, Roscommon
and Mayo, representing a complete sample group for
this survey. The postal details were obtained from the
HSE database, which captured all GPs in the counties.
However, the data source did not include any informa-
tion that would provide any description of the GPs who
would respond to this survey. The respondents were
g i v e na no p t i o nw h e t h e rt or e m a i na n o n y m o u so rt o
identify themselves in this survey. A pre-paid return
envelope was provided to enhance responses [15]. This
study took place between 10
th July and 31
st August
2008. The study was granted the ethical approval from
the University Research Ethics Committee of the
National University of Ireland, Galway.
Data analysis
All the collected data were compiled into a database and
further analysed using Statistical Package for the Social
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tive analyses, different inferential statistical analyses
were performed. The ordinal five-level Likert items
(strongly agree, agree, neither, disagree and strongly dis-
agree) were collapsed to three data points (agree,
neither, disagree) for inferential statistical analyses.
Using Pearson Chi square (c
2) tests, we examined the
associations (a) between prevalence of EMR adoption
and practice premise, (b) between current use of CDS
mechanisms and perceived value of different CDS
mechanisms in assisting GPs’ prescribing decision, and
(c) between the GPs’ preparedness towards future CDS-
eP adoption, and duration in general practice (data were
categorized into two categories according to median
general practice), practice premise and current use of
CDS mechanisms. If the assumptions for a c
2 test were
not met, Fisher’s exact or linear by linear association
test would be applied as an alternative test. Besides,
Spearman’s correlation tests were performed to examine
the relationship between the different aspects of GPs’
preparedness, and their perceived barriers towards
future CDS-eP adoption. In addition, we investigated
whether the duration of individual GP’s practice influ-
enced the frequency of EMR adoption, their prepared-
ness and their perceived barriers towards CDS-eP
adoption using one-way Anova tests. The level of statis-
tical significance for all inferential analyses was defined
at p-value less than 0.05.
An additional component to survey “the GPs’ feelings
when the alerts flagged by CDS-eP during the prescrib-
ing process” was reported incomprehensive and not
answered by majority of the respondents. It was hence
omitted from data analysis.
Results
We obtained an overall response rate of 37% (98 out of
262) in this study. Nearly 45% (44 out of 98) of respon-
dents identified themselves in this survey.
Overview of individual practice and EMR prevalence
The practice durations of the respondents were variable,
ranging from one to 39 years. Half of them had at least
19 years of experience in the field of general practice.
There were nearly equal proportions of GPs currently
working in either city (30.9%) or rural (32%) areas, while
37.1% had a mixed practice. Approximately 60% of them
practiced in a group of at least two whole-time equiva-
lent GPs, with the remaining 40% operating single-hand-
edly. Among those practising in groups, half practiced in
a group of two whole-time equivalent practitioners, fol-
lowed by 31% in a group of three, 13% in a group of
four, 3% in a group of five and 2% in a group of eight.
Ninety-two percent of the respondents had adopted an
EMR system in their practice, chosen from these soft-
ware products available in Ireland - HEALTH one™,
Medicom® or GP Mac. There was a high prevalence of
EMR adoption among both single-handed and group-
practice GPs. However, there is a significant correlation
between EMR adoption and practice premises, whereby
approximately 18% of single-handed GPs still employed
the conventional paper system in keeping the consulta-
tion record for their patients, as compared to 2% of
group-practice GPs (Fisher exact test, p = 0.008) (Figure
1). However, their duration of practice did not seem to
influence the frequency of EMR adoption in their
practice.
Current use of CDS mechanisms and their values in
prescribing process
With regard to the types of CDS mechanisms presently
used by the GPs in their prescribing practice, 45% of
them relied solely on the conventional paper mechan-
isms, such as BNF, MIMS, and local or international
guidelines. Only 5% of GPs referred to computer or
internet-based information exclusively. The remaining
half of the respondents utilized combinational electronic
and paper mechanisms in supporting their prescribing
decisions. In addition, two respondents reported refer-
ring to the specialists in hospital for prescribing advice
occasionally.
Forty-six percent of the GPs considered paper
mechanisms to be superior to electronic CDS mechan-
isms in assisting their prescribing practice. Almost 38%
recognized electronic mechanisms as equally valuable to
the paper mechanisms as a decision support tool in
their prescribing practice. There was a significant corre-
lation between the current CDS mechanisms in use by
the GPs and their evaluation of these mechanisms (Lin-
ear by Linear Association, p = 0.017) (Figure 2).
Although the majority who solely employed paper
mechanisms valued more the paper mechanisms, one
third perceived that electronic mechanisms were not
inferior to the paper mechanism. Among respondents
who currently utilized the combinational mechanisms,
as many as 70% acknowledged the value of electronic
CDS mechanisms in guiding their prescribing decision.
Attitudes and preparedness towards CDS-eP adoption
Seventy percent of the respondents believed that CDS-
eP has the capacity to improve quality, while nearly 84%
considered that using this new mechanism may reduce
prescribing errors (Table 1). About one in five respon-
dents were concerned that this mechanism may reduce
their decision making power in prescribing. Ninety-four
percent of GPs expressed their readiness to learn and
use this new mechanism, and more than 60% were will-
ing to invest greater resources in its adoption in future.
Seventy-three percent of the respondents were unfami-
liar with what CDS-eP is and how it is used in clinical
prescribing practice. There was no statistically signifi-
cant correlation between the GPs’ preparedness towards
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practice premises or current use of CDS mechanisms.
Potential barriers impeding CDS-eP adoption
Among the six major pre-selected barriers, the top three
barriers ranked by at least 60% of respondents were
beyond individual capacity of control. The lack of a stra-
tegic national implementation plan was perceived as the
main obstacle for future implementation of CDS-eP in
their clinical practice (Table 2), followed by the lack of
financial incentives and of acceptable, standardized soft-
ware products. Among the subsequent three barriers
specific to the prescribers, high sensitivity of drug-drug
interaction and medication allergy markers present
within CDS-eP was the main concern. Forty-four per-
cent expressed concern regarding their degree of flex-
ibility to override the suggestions or decision made by
Figure 1 Adoption of EMR among GPs in single-handed and group practices.
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convincing evidence on the mechanism’s effectiveness as
an impediment towards its future adoption. There was
no statistically significant correlation between the per-
ceived barriers and the GPs’ preparedness towards the
adoption of such new mechanism.
Presumptive responses towards alerts from CDS-eP
Medication allergies (91%) and drug-drug interaction
(82%) flagged by CDS-eP would be the two alerts
accepted by the majority of GPs most of the times dur-
ing the prescribing process, while a cost-related alert
would be the least prioritized element (Figure 3).
General comments on CDS-eP
A total of 13 comments were provided by the respon-
dents with some illustrated in the Additional File 1.
Concern was expressed regarding the potential interfer-
ence with their prescribing independence, as well as the
system’s efficiency as an up-to-date clinical decision
support tool. With regards to hypersensitivity of drug-
drug interaction markers, a GP commented that “really
depend(s) on the specificity e.g. I know that angioten-
sin-converting enzyme (ACE) inhibitors and diuretics
interact. This may be why I prescribe them (e.g. for
enhanced antihypertensive effect or to avoid ACEI-
induced hyperkalaemia). I probably would get frustrated
if the alert is flagged every time I attempt to co-pre-
scribe these medication and especially if the alert sub-
stantially delayed my prescribing (e.g. by 20 seconds)”.
Discussion
In this study, majority of the GP respondents displayed
positive attitudes towards the potential benefits brought
by CDS-eP. They expressed their readiness to embrace
the new mechanism through their willingness to learn
and to invest greater resources in adopting this mechan-
ism. In addition, the high prevalence of EMR adoption
in the clinical practice has set a potential platform for
future incorporation of CDS-eP into e-Prescribing sys-
tem in order to optimize its functions. Moreover, there
is an increased utilization of electronic CDS mechanisms
in the Irish primary care setting. The positive value of
such mechanisms in aiding their prescribing decision-
making process has been acknowledged by the GPs. An
increased confidence in the application, together with
improved availability and accessibility to electronic
sources may have contributed to emergence of this tran-
sitional phase, from relying solely on paper mechanisms
to start exploring the electronic mechanisms. The
assessment of the source of the specific electronic
mechanism was beyond the scope of this study, and
remains as an interesting aspect to explore further. Also,
the high rates of appreciation for the value of CDS
mechanisms and willingness for further investment may
be specific to the sub-group of GPs who were likely to
respond to this survey.
Worldwide, inappropriate prescribing in the commu-
nity setting, particularly among elderly populations has
been reported, with some resulting in adverse medica-
tion events [16-18]. Currently, there is no national pro-
gramme or policy in place to collect and evaluate data
related to medication errors in the Irish primary care
setting. A report regarding the medication safety scheme
from Tallaght Hospital in Dublin revealed that nearly
15% of 102 prescribing errors in the community setting
Table 1 GPs’ attitudes and preparedness towards CDS-eP
Statements Agree Neutral Disagree
I am familiar with what CDS-eP is and how it is used in clinical prctice (N = 93) 27% 12% 61%
I believe that CDS-eP has the capacity to improve prescribing quality (N = 91) 71% 28% 1%
I believe that using CDS-eP may reduce prescribing errors (N = 91 84% 14% 2%
I believe that CDS-eP may reduce my decision making power in prescribing (N = 90) 19% 32% 49%
I am open to learning/using new CDS-eP (N = 95) 94% 4% 2%
My practice is willing to invest greater resources in CDS-eP in the future (N = 92) 62% 26% 12%
N – number of respondents, excluding missing responses. Total respondents = 98
Table 2 Potential barriers impeding implementation of CDS-eP in general practice
Perceived barriers Agree Neutral Disagree
Lack of convincing evidence regarding its effectiveness (N = 88) 22% 44% 34%
High sensitivity of drug – drug interaction or drug allergy markers (N = 85) 46% 41% 13%
Concern about the degree of flexibility for the physician to override CDS-eP (N = 88) 44% 32% 24%
Lack of financial incentives (N = 87) 70% 24% 6%
Lack of acceptable, standardized product software (N = 88) 61% 33% 7%
Lack of a strategic plan for implementation (N = 89) 78% 20% 2%
N – number of respondents, excluding missing responses. Total respondents = 98
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errors accounted for 10 - 20% of legal claims against
GPs in the United Kingdom and Ireland [20,21].
Since its inception, incorporation of CDS-eP into e-
Prescribing systems has encountered challenges ranging
from national standardized implementation to individual
prescriber endorsement for its application in the clinical
setting. The absence of a strategic national action plan
was perceived as the greatest barrier of all. Further pro-
gress is awaited with the recent HSE announcements on
its plan to invest in a national e-Prescribing system and
IT-related projects [10,11]. Financial incentives often act
as a driving force to accelerate adoption of the new
initiative. Its long term implication for cost-saving
would be significant. An example is a recent initiative
by the Department of Health and Human Services in
United States to launch an incentive payments scheme
to eligible professional successful electronic prescribers,
via Medicare over a five-year period from 2009. It is
expected to save up to US $156 m by avoiding adverse
medication events over the course of the programme
[2]. McMullin et. al. reported that application of e-Pre-
scribing systems with an integrated CDS mechanism in
primary care had shifted the prescribing behaviour away
from the high cost therapies and lowered prescription
c o s t s .T h es a v i n g sf r o mt h ea ltered prescribing beha-
viours offset the subscription cost of the system [22].
More studies are needed to illustrate the cost-and-bene-
fit analysis of CDS-eP adoption to convince authorities
that investment is worthwhile in the primary care set-
ting. Designation of standardized, acceptable and user-
friendly software products for CDS-eP is a demanding
process, especially with increasing emphasis on evi-
dence-based prescribing [23].
Hypersensitivity of the drug allergy or drug-drug
interaction alerts and concern over flexibility as a pre-
scriber to override CDS-eP are the GP-specific barriers.
Hypersensitivity of alerts is often attributed to frequent
flagging of trivial or unnecessary alerts and in high
volume. For example, running an allergy or drug-drug
interaction check against medication history instead of
current medication regimen [24]. Studies have indicated
40 - 96% of electronic medication safety alerts were
overridden by physicians [24-26]. Factors contributing
to overriding the alerts were poor specificity and their
low significance in clinical context, alerts overload inter-
rupting workflows and constant time pressure in clinical
practice. Moreover, known interactions with justifiable
benefits greater than risks and patients’ resistance to
change have also led to non-adherence to the alerts
[8,24-29]. Concern over CDS-eP interfering with the
prescribers’ decision making power, as expressed by
one-fifth of GP respondents may become an inherent
factor contributing to the resistance to adopting the
mechanism in individual practice. It is proposed that
allowing prescribers to set their desirable threshold of
alerts severity may be expected to improve the alerts
acceptance rate [24,28]. Also, a “smarter” system
designed to stratify various medication alerts to their
clinical relevance and utilize a set of mandatory alerts
may improve prescribing safety [30]. In this study, more
than 80% of GP respondents reported that they would
accept drug allergy and drug-drug interaction alerts
most of the time, if CDS-eP is in place.
Figure 3 Presumptive responses towards potential alerts flagged by CDS-eP during prescribing process.
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CDS-eP in enhancing prescribing quality [1,3-6]. The lack
of training and exposure towards e-Prescribing-related
issues may have contributed to the high degree of unfami-
liarity among the GPs and their perception of lacking con-
vincing evidence on the mechanism’s effectiveness.
This study should be viewed with the following limita-
tions is mind. A 37% response rate may have provided an
unrepresentative sample that has limited views in this
area. Besides, the survey was carried out among GPs in
three out of 26 Irish counties, hence the results may not
be generalizable to reflect the views of the entire Irish
primary care. However this is the first study of its kind in
Ireland and, at the very least, provides a valuable bench-
mark. Although there is a high EMR adoption rate (92%)
among our respondents, future research should attempt
to assess the attitudes and opinions of the non-respon-
dents towards e-Health initiative.
We propose a multidisciplinary and multidimensional
approach to make further progression with CDS-eP. At
national level, establishment of an expert review panel spe-
cific to e-Prescribing and CDS-eP is needed to evaluate the
current Irish e-Health initiatives (e.g. e-Prescribing system,
e-transfer of medical information), assess in depth the
existing barriers and draft practical recommendations for
implementation. With a score of 42 points out of 100 for
the e-Health component in the recent Euro Health Consu-
mer Index (EHCI) 2008, more concerted efforts are
needed by all stakeholders [31]. At local level, such as in
the West of Ireland, a pilot feasibility study of CDS-eP
adoption in selected practices is recommended.
Conclusions
Prescribers’ opinions and attitudes are a pre-requisite to
determine the success of CDS-eP adoption in clinical prac-
tice. The results from this study reflect encouraging atti-
tudes of GPs in the West of Ireland towards CDS-eP,
potentially paving the way for its future adoption, as part
of a better integrated care pathway for patients. Major bar-
riers identified require to be overcome for future progres-
sion through multidisciplinary collaboration.
Additional file 1: Additional comments from GP respondents on
CDS-eP.G P s ’ views with regards to their recognition and concerns on
CDS-eP mechanism.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-6947-10-2-
S1.DOC]
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